Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
504 Brookwood Blvd
Homewood, AL 35209Phone+1 205-871-9661Fax+1 205-975-7080
Education & Training
University of Alabama Medical CenterFellowship, Allergy and Immunology, 2009 - 2011- University of Alabama Medical CenterResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
AL State Medical License 2008 - 2025
American Board of Allergy and Immunology Allergy & Immunology
Clinical Trials
- A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor Start of enrollment: 2021 Feb 05
Roles: Principal Investigator
Publications & Presentations
PubMed
- Hereditary angioedema: Patient health care experiences within underrepresented racial and ethnic groups in the United States.Timothy Craig, Alan P Baptist, John Anderson, Rafael H Zaragoza-Urdaz, Autumn F Burnette
Annals of Allergy, Asthma & Immunology. 2025-01-20 - Long-term prevention of hereditary angioedema attacks with lanadelumab in adolescents.Timothy Craig, Raffi Tachdjian, Jonathan A Bernstein, John Anderson, Christina Nurse
Annals of Allergy, Asthma & Immunology. 2024-12-01 - 2 citationsReal-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis.John Anderson, Daniel Soteres, Raffi Tachdjian, Jennifer Mellor, Lucy Earl
Allergy and Asthma Proceedings. 2024-11-01
Press Mentions
For Some, Allergies Are Ongoing StruggleSeptember 21st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
